Skip to main content

Chronic Diabetes Complications Bidirectionally Linked to Mental Health Disorders

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 29, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Aug. 28, 2024 -- There is a consistent, bidirectional association between chronic diabetes complications (CDCs) and mental health disorders (MHDs), according to a study published online July 15 in Diabetes Care.

Maya Watanabe, from the University of Michigan in Ann Arbor, and colleagues examined bidirectional associations between the timing of CDCs and MHDs in individuals with type 1 or type 2 diabetes. The analysis included 553,552 individuals (44,735 with type 1 diabetes, 152,187 with type 2 diabetes, and 356,630 without diabetes).

The researchers found that having a CDC increased the risk for developing an MHD (hazard ratio, 1.9 to 2.9), with a higher risk observed in older age strata. Furthermore, having an MHD increased the risk for developing a CDC (hazard ratio, 1.4 to 2.5), with a higher risk observed among those ages 0 to 19 years. In younger individuals (younger than 60 years), those with type 1 diabetes were more likely to have CDCs, while those with type 2 diabetes were more likely to have MHDs. However, the bidirectional relationship between CDCs and MHDs was not affected by diabetes type.

"Most likely, a combination of direct and indirect effects and shared risk factors drive the association we are seeing," Watanabe said in a statement. "Diabetes care providers may be able to simultaneously prevent the risk of multiple complications by providing interventions to treat these shared risk factors."

Several authors disclosed ties to the pharmaceutical and medical device industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted August 2024

Read this next

Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases

THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...

Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials

THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...

Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors

THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.